| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:438.)
© 2004 American Heart Association, Inc.
Original Contributions |
From Clinica Neurologica (A.P., E. Del Z., E.B., N.M.A., A.P.), Clinica Cardiologica (D.A.), and III Laboratorio di Analisi, Biotecnologie (S.A., A.A.), Università degli Studi di Brescia, Brescia, and Istituto di Statistica Medica e Biometrie, Università degli Studi di Pavia, Pavia (M.G.), Italia.
Correspondence to Alessandro Pezzini, Clinica Neurologica, Università degli Studi di Brescia, P. le Spedali Civili, 1, 25100 Brescia, Italia. E-mail ale_pezzini{at}hotmail.com
Background and Purpose The effect of apolipoprotein E (APOE) polymorphisms on stroke risk may be influenced by the coexistence of modifiable predisposing conditions. We explored the interactions of APOE genotypes and conventional risk factors in a case-control study of young adults with cerebral infarct.
Methods We analyzed 124 consecutive patients (age, 34.7±7.3 years) and 147 age- and sex-matched controls. APOE genotypes were determined by restriction fragment-length polymorphism analysis.
Results The prevalence of the
4 allele and
34 genotype was slightly higher in cases than in controls (0.125 versus 0.071 and 0.242 versus 0.136, respectively). Carriers of the
34 genotype and
4 allele were associated with an increased risk of stroke on multivariate analysis compared with the
33 genotype and non-
4 carriers, respectively (odds ratio [OR], 2.29; 95% confidence interval [CI], 1.10 to 4.76; and OR, 2.27; 95% CI, 1.13 to 4.56). ORs for stroke were 2.99 (95% CI, 1.64 to 5.45), 2.69 (95% CI, 1.25 to 5.77), and 5.39 (95% CI, 1.59 to 18.30) for smokers with the
33 genotype, nonsmokers with the
34 genotype, and smokers with the
34 genotype, respectively, compared with nonsmokers with the
33 genotype. Similar results were obtained when
4 carriers and non-
4 carriers were compared in the same interaction model. No significant interaction between APOE and hypertension was found.
Conclusions In young adults, the APOE
4 allele and cigarette smoking act synergistically, increasing an individuals propensity to have a cerebral ischemic event. This finding may help in determining an individuals predisposition to stroke and more targeted preventive interventions.
Key Words: apolipoproteins cigarette smoking polymorphism risk factors
This article has been cited by other articles:
![]() |
W. Lalouschek, G. Endler, M. Schillinger, K. Hsieh, W. Lang, S. Cheng, P. Bauer, O. Wagner, and C. Mannhalter Candidate Genetic Risk Factors of Stroke: Results of a Multilocus Genotyping Assay Clin. Chem., April 1, 2007; 53(4): 600 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Humphries, J. A. Cooper, P. J. Talmud, and G. J. Miller Candidate Gene Genotypes, Along with Conventional Risk Factor Assessment, Improve Estimation of Coronary Heart Disease Risk in Healthy UK Men Clin. Chem., January 1, 2007; 53(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pezzini, M. Grassi, E. D. Zotto, S. Archetti, R. Spezi, V. Vergani, D. Assanelli, L. Caimi, and A. Padovani Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults Stroke, March 1, 2005; 36(3): 533 - 539. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |